NEW YORK, June 12 - Genome Quebec, the provincial arm of the Canadian genomics research organization Genome Canada, has appointed Paul L'Archevêque to the position of president and chief executive officer, the organization said Tuesday. 

L'Archevêque, a former vice president for marketing at Glaxo Wellcome, now GlaxoSmithKline, said in a statement he would strive to bridge the private and public sectors in raising money and awareness of genomics in Quebec. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.